Probucol, an approved anti-cholesterol drug, inhibits ABCA1. But, ABCA1 is upregulated in high LDL and downregulated in breast cancer, suggesting that inhibitions of this gene might not lead to desired treatment outcome for breast cancer [36]. The gene discussed is ABCA1; the disease is breast carcinoma.